BioScrip Schedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call
25 Février 2019 - 8:00PM
BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the
largest independent national provider of infusion and home care
management solutions, today announced that the Company will issue
its financial results press release for the fourth quarter and full
year ended December 31, 2018 on Thursday, March 14, 2019 before the
opening of the U.S. financial markets.
Daniel E. Greenleaf, President and Chief Executive Officer, and
Stephen Deitsch, Senior Vice President, Chief Financial Officer and
Treasurer, will host a conference call as follows:
Date |
March
14, 2019 |
Time |
9:00
a.m. ET |
Toll
free (U.S.) |
(877)
423-9820 |
International |
(201)
493-6749 |
Webcast
(live and replay) |
https://78449.themediaframe.com/dataconf/productusers/bios/mediaframe/29020/indexl.html |
|
Or |
|
www.bioscrip.com |
|
|
The online replay will be available within two hours of the
call’s completion in the Investor Relations section of BioScrip’s
web site at: www.bioscrip.com.
About BioScrip, Inc.BioScrip,
Inc. is the largest independent national provider of infusion and
home care management solutions, with approximately 2,100 teammates
and nearly 70 service locations across the U.S. BioScrip partners
with physicians, hospital systems, payors, pharmaceutical
manufacturers and skilled nursing facilities to provide patients
access to post-acute care services. BioScrip operates with a
commitment to bring customer-focused pharmacy and related
healthcare infusion therapy services into the home or
alternate-site setting. By collaborating with the full spectrum of
healthcare professionals and the patient, BioScrip provides
cost-effective care that is driven by clinical excellence, customer
service, and values that promote positive outcomes and an enhanced
quality of life for those it serves.
Investor ContactsStephen DeitschChief Financial
Officer & TreasurerT: (720)
697-5200stephen.deitsch@bioscrip.com |
|
Kalle
Ahl, CFAThe Equity GroupT: (212) 836-9614kahl@equityny.com |
|
|
|
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024